Delivery Order SPE2DB22D2005-SPE2DB25FJQJ3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Methimazole 10 mg tablets (180-count units) with a ceiling value of $4,294.24. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by September 26,...
- The Defense Logistics Agency awarded a delivery order valued at $1,557.34 to AmerisourceBergen Drug Corp for the supply of Methimazole 5 mg tablets in quantities of 90 units. This firm fixed price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive procurement. The contractor will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methimazole 5 mg tablets in quantities of 90 units, with a ceiling value of $1,475.78. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a continuation of pharmaceutical support under AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $5,099.94 to AmerisourceBergen Drug Corp for the supply of Methimazole 5 mg tablets (180-count units) with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 14, 2025, with performance originating from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,001,865 units of the pharmaceutical product Methimazole 10 mg Tablets. The delivery order, valued at $1,182.34, has a firm fixed price and a performance period ending on March 19, 2024. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,572.06 firm fixed price delivery order is for the supply of Methimazole 5 mg tablets. The contract has an ultimate completion date of March 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a broader indefinite delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,169.78 to Amerisourcebergen Drug Corporation for the supply of 90 boxes of 5 mg Methimazole tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order period of performance spans from September 12, 2023 through September 13, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's...
- The Defense Logistics Agency awarded a $136,890 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 boxes of 5 mg methimazole tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for shipment of the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 22, 2023. As a major provider of medical supplies to the U.S. Department of Defense, Amerisourcebergen will fulfill this order from its...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $42,192.08 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical (DLA) to provide 4562266100 units of Methimazole 5 mg tablets. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order is for a one day period of performance spanning September 21 through September 22, 2023. No subcontractors or set aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of Methimazole 5 mg tablets, with a potential value of $2,060.56 and a completion date of January 22, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and medical supplies to U.S. government...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQJ3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methimazole 5 mg tablets (90-count units) under a firm fixed price contract valued at $9,530.95. The order was competitively awarded without set-aside designation and is set for completion by July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the supplier to furnish a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical federal pharmaceutical distributor, supplying medications across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio demonstrates consistent success in competing for competitively awarded delivery orders with DLA, ranging from small transactions to substantial orders exceeding $45,000. This particular order for Methimazole, an antithyroid medication, reflects the company's ongoing role as a primary vendor for federal medical procurement needs supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 7/24/25 |